This study assessed the real‐world effectiveness and safety of a fixed‐dose combination (FDC) of metformin and empagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM).
Wei-Jian Ke, Ying-Hong Kong, Song-Bo Fu et al.· Journal of Diabetes· 0 citations
Current therapeutic strategies targeting CD4+ T cells, including traditional Chinese herbs, biologic agents, nonsteroidal mineralocorticoid receptor antagonists, sodium-glucose cotransporter 2 inhibitors and stem cell therapy are outlined, and their potential and limitations in balancing T cell subsets and alleviating...
Ding-Chang Zheng, Ling-Fei Zhang, Han-Xue Li et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.